{"content":"<li class=\"n-box-item date-title\" data-end=\"1465531199\" data-start=\"1465444800\" data-txt=\"Sunday, December 22, 2019\">Thursday, June  9, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3188243\" data-ts=\"1465512235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188243-urban-outfitters-warns-on-current-quarter-comparable-retail-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Outfitters warns on current quarter comparable retail sales</a></h4><ul>     <li>Urban Outfitters (NASDAQ:<a href=\"https://seekingalpha.com/symbol/URBN\" title=\"Urban Outfitters, Inc.\">URBN</a>) <font color=\"red\">-6.7%</font> AH after saying that same-store sales have been <a href=\"http://www.marketwatch.com/story/urban-outfitters-warns-of-weak-sales-shares-fall-2016-06-09-174853655\" target=\"_blank\">slower than expected</a> so far this quarter.</li>     <li>UBRN says in an <a href=\"http://www.sec.gov/Archives/edgar/data/912615/000119312516617827/d190877d10q.htm\" target=\"_blank\">SEC filing</a> that comparable retail segment net sales for its FQ2 that began May 1 had fallen by a percentage in the mid single-digits, vs. analyst expectations for the current quarter's comparable sales to increase 1.1%; URBN reported a 4% gain in comp sales in the year-ago FQ2 and 1% in FQ1 2017.</li>     <li>URBN has reported lower profit on a Y/Y basis in seven of the past nine quarters.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188243\" data-linked=\"Urban Outfitters warns on current quarter comparable retail sales\" data-tweet=\"$URBN - Urban Outfitters warns on current quarter comparable retail sales https://seekingalpha.com/news/3188243-urban-outfitters-warns-on-current-quarter-comparable-retail-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3188243-urban-outfitters-warns-on-current-quarter-comparable-retail-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188240\" data-ts=\"1465510700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188240-h-and-r-blockplus-6-on-earnings-beat-dividend-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;R Block +6% on earnings beat, dividend increase</a></h4><ul>\n<li>H&amp;R Block (NYSE:<a href=\"https://seekingalpha.com/symbol/HRB\" title=\"H&amp;R Block Inc.\">HRB</a>) <font color=\"green\">+6.3%</font> AH after reporting <a href=\"https://seekingalpha.com/news/3188209-h-and-amp-r-block-beats-0_01-beats-revenue\" target=\"_blank\">FQ4 earnings</a> that beat expectations and <a href=\"https://seekingalpha.com/news/3188203-h-and-r-block-declares-0_22-dividend\" target=\"_blank\">hiking its dividend by 10%</a>.</li>\n<li>HRB gives its final tally of U.S. tax return volume for the latest tax season,  with total returns down 4.5%, including a 5.8% decline in assisted  returns and a 2.6% drop in returns prepared with its software.</li>\n<li>HRB says it is investing in initiatives aimed at attracting  more customers during the current year, but <a href=\"http://www.marketwatch.com/story/hr-block-reports-lower-profit-tops-expectations-2016-06-09\" target=\"_blank\">offers no details</a> except  that funding will occur through previously announced cost-cutting  efforts.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188240\" data-linked=\"H&amp;R Block +6% on earnings beat, dividend increase\" data-tweet=\"$HRB - H&amp;R Block +6% on earnings beat, dividend increase https://seekingalpha.com/news/3188240-h-and-r-blockplus-6-on-earnings-beat-dividend-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3188240-h-and-r-blockplus-6-on-earnings-beat-dividend-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188233\" data-ts=\"1465508189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188233-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MJN' title='Mead Johnson Nutrition Company'>MJN</a> <font color='green'>+8.0%</font>. <a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+6.1%</font>. <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+1.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='red'>-15.6%</font>. MPEL <font color='red'>-12.8%</font>. <a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='red'>-11.9%</font>. <a href='https://seekingalpha.com/symbol/MGA' title='Magna International Inc.'>MGA</a> <font color='red'>-11.9%</font>. <a href='https://seekingalpha.com/symbol/MFRM' title='Mattress Firm Holding Corp.'>MFRM</a> <font color='red'>-10.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188233\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MJN $HRB $BG - After Hours Gainers / Losers https://seekingalpha.com/news/3188233-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3188233-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188219\" data-ts=\"1465505304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188219-antero-resources-to-buy-marcellus-acreage-from-southwestern-for-450m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources to buy Marcellus acreage from Southwestern for $450M</a></h4><ul>\n<li>Antero Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/AR\" title=\"Antero Resources Corporation\">AR</a>) <font color=\"red\">-2.5%</font> AH after agreeing to acquire 55K net acres and 14M cfe/day of net production in West Virginia's Marcellus Shale from Southwestern Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/SWN\" title=\"Southwestern Energy Co.\">SWN</a>) for $450M.</li>\n<li>AR says substantially all the acreage will be dedicated to Antero  Midstream Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/AM\" title=\"Antero Midstream Partners\">AM</a>) for gas gathering, compression, processing and water services.</li>\n<li>To fund the deal, AR announces a public offering of 26.75M common shares, with an underwriters option to purchase up to an additional ~4M shares.</li>\n<li>SWN says it plans to use the cash from the deal to reduce  the principal balance of its $750M term loan due in  November 2018.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188219\" data-linked=\"Antero Resources to buy Marcellus acreage from Southwestern for $450M\" data-tweet=\"$AR $AR $SWN - Antero Resources to buy Marcellus acreage from Southwestern for $450M https://seekingalpha.com/news/3188219-antero-resources-to-buy-marcellus-acreage-from-southwestern-for-450m?source=tweet\" data-url=\"https://seekingalpha.com/news/3188219-antero-resources-to-buy-marcellus-acreage-from-southwestern-for-450m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188209\" data-ts=\"1465504041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188209-handr-block-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;amp;R Block beats by $0.01, beats on revenue</a></h4><ul>\n<li>H&amp;R Block (NYSE:<a href=\"https://seekingalpha.com/symbol/HRB\" title=\"H&amp;R Block Inc.\">HRB</a>): FQ4 EPS of $3.16 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Revenue of $2.3B (flat Y/Y) <font color=\"green\">beats by $20M</font>.</li>\n<li>Shares <font color=\"green\">+7%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188209\" data-linked=\"H&amp;amp;R Block beats by $0.01, beats on revenue\" data-tweet=\"$HRB - H&amp;R Block beats by $0.01, beats on revenue https://seekingalpha.com/news/3188209-handr-block-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3188209-handr-block-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188206\" data-ts=\"1465503885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPHS\" target=\"_blank\">SPHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188206-sophiris-bios-lead-product-candidate-shows-encouraging-action-in-small-mid-stage-prostate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sophiris Bio&#39;s lead product candidate shows encouraging action in small mid-stage prostate cancer study; shares up 51% after hours</a></h4><ul>\n<li>Nano cap Sophiris Bio (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPHS\" title=\"Sophiris Bio\">SPHS</a>) zooms up <font color=\"green\">51</font>% after hours on robust volume in response to its announcement of positive results from an 18-subject Phase 2a clinical trial assessing lead product candidate topsalysin (PRX302) for the treatment of localized prostate cancer.</li>\n<li>The open-label study was conducted at the University College London. Each participant received a single injection of topsalysin directly into a clinically significant prostate cancer lesion. The primary endpoint was safety and tolerability while secondarily evaluating efficacy determined by the change in the treated lesion on target biopsy at month 6.</li>\n<li>The overall response rate was 50% (n=9/18). Seven (38.9%) were partial responders and two (11.1%) experienced a complete response (complete ablation).</li>\n<li>The injection was well-tolerated with no new safety signals observed.</li>\n<li>Sophiris intends to advance topsalysin to Phase 2 development.</li>\n<li>\n<a href=\"http://www.sophirisbio.com/prx-302/\" target=\"_blank\">Topsalysin </a>is a modified recombinant protein engineered to be selectively activated by an enzyme in the prostate. It is administered via direct injection into the prostate gland where it kills cancer cells without damaging surrounding tissue.</li>\n<li>The company will host a conference call today at 5:00 pm ET to discuss the results.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188206\" data-linked=\"Sophiris Bio&#39;s lead product candidate shows encouraging action in small mid-stage prostate cancer study; shares up 51% after hours\" data-tweet=\"$SPHS - Sophiris Bio&#39;s lead product candidate shows encouraging action in small mid-stage prostate cancer study; shares up 51% after hours https://seekingalpha.com/news/3188206-sophiris-bios-lead-product-candidate-shows-encouraging-action-in-small-mid-stage-prostate?source=tweet\" data-url=\"https://seekingalpha.com/news/3188206-sophiris-bios-lead-product-candidate-shows-encouraging-action-in-small-mid-stage-prostate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188195\" data-ts=\"1465502380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188195-emerge-energyplus-30-to-reach-highest-level-since-september\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerge Energy +30% to reach highest level since September</a></h4><ul>     <li>Emerge Energy Services (<a href=\"https://seekingalpha.com/symbol/EMES\" title=\"Emerge Energy Services LP\">EMES</a> <font color=\"green\">+30.2%</font>) surges ~30% on 10x the normal trading volume to reach its highest level since September.</li>     <li>Bloomberg speculates that the move may be a delayed reaction to Goldman Sachs analyst Waqar Syed's note earlier this week that said the key to EMES improving its balance sheet is selling its fuels business, which could fetch $50M and possibly more, given the current \"buyer\u2019s market.\u201d</li>     <li>Syed estimates that at peak Ebitda, EMES distributable cash flow may be as high as $1.53/unit; if EMES is paying that level of distribution, the unit may be  priced \u201csignificantly\u201d above where it currently trades.</li>     <li>Frac sand peers also are higher: <a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a> <font color=\"green\">+2.8%</font>, <a href=\"https://seekingalpha.com/symbol/HCLP\" title=\"Hi-Crush Partners LP\">HCLP</a> <font color=\"green\">+2%</font>, <a href=\"https://seekingalpha.com/symbol/FMSA\" title=\"Fairmount Santrol, Inc.\">FMSA</a> <font color=\"green\">+1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188195\" data-linked=\"Emerge Energy +30% to reach highest level since September\" data-tweet=\"$EMES $EMES $SLCA - Emerge Energy +30% to reach highest level since September https://seekingalpha.com/news/3188195-emerge-energyplus-30-to-reach-highest-level-since-september?source=tweet\" data-url=\"https://seekingalpha.com/news/3188195-emerge-energyplus-30-to-reach-highest-level-since-september\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188184\" data-ts=\"1465501432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188184-valeant-mulling-sale-of-egyptian-drug-maker-amoun-to-accelerate-debt-reduction-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant mulling sale of Egyptian drug maker Amoun to accelerate debt reduction; shares up 5%</a></h4><ul>\n<li>Valeant Pharmaceuticals (VRX <font color=\"green\">+5.2%</font>) jumps on increased volume in response to the news that it is considering selling Egyptian drug maker Amoun Pharmaceutical in order to speed up its debt reduction. Goldman Sachs is advising.</li>\n<li>Valeant acquired Amoun in July 2015 for ~$800M.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2635925-valeant-buys-amoun-pharma-for-800m\" target=\"_blank\">Valeant buys Amoun Pharma for $800M</a> (July 17, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188184\" data-linked=\"Valeant mulling sale of Egyptian drug maker Amoun to accelerate debt reduction; shares up 5%\" data-tweet=\"$BHC - Valeant mulling sale of Egyptian drug maker Amoun to accelerate debt reduction; shares up 5% https://seekingalpha.com/news/3188184-valeant-mulling-sale-of-egyptian-drug-maker-amoun-to-accelerate-debt-reduction-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3188184-valeant-mulling-sale-of-egyptian-drug-maker-amoun-to-accelerate-debt-reduction-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188182\" data-ts=\"1465500710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188182-recipient-of-second-sights-argus-ii-regains-vision-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recipient of Second Sight&#39;s Argus II regains some vision; shares up 8%</a></h4><ul>\n<li>Thinly traded micro cap Second Sight Medical (<a href=\"https://seekingalpha.com/symbol/EYES\" title=\"Second Sight Medical Products\">EYES</a> <font color=\"green\">+8.3%</font>) heads north on almost a 5x surge in volume in apparent response to a <a href=\"http://video.foxnews.com/v/4931865768001/blind-man-sees-again/?#sp=show-clips\" target=\"_blank\">Fox News story</a> about a totally blind recipient of the company's <a href=\"http://www.secondsight.com/argus-ii-retinal-prosthesis-system-en.html\" target=\"_blank\">Argus II Retinal Prosthesis System</a> who has regained some vision.</li>\n<li>The device converts images captured by a miniature camera mounted on the patient's glasses into a series of tiny electrical pulses that are wirelessly transmitted to an array of electrodes implanted on the surface of the retina. The pulses stimulate the remaining viable retinal cells resulting in the perception of patterns of light. The patient regains some visual capability by learning to interpret the visual patterns.</li>\n<li>The FDA approved the product in February 2013 under its Humanitarian Device Exemption.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188182\" data-linked=\"Recipient of Second Sight&#39;s Argus II regains some vision; shares up 8%\" data-tweet=\"$EYES - Recipient of Second Sight&#39;s Argus II regains some vision; shares up 8% https://seekingalpha.com/news/3188182-recipient-of-second-sights-argus-ii-regains-vision-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3188182-recipient-of-second-sights-argus-ii-regains-vision-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188180\" data-ts=\"1465500300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BUFF\" target=\"_blank\">BUFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188180-valuation-concerns-perk-up-again-on-blue-buffalo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valuation concerns perk up again on Blue Buffalo</a></h4><ul>\n<li>Blue Buffalo Pet Products (<a href=\"https://seekingalpha.com/symbol/BUFF\" title=\"Blue Buffalo\">BUFF</a> <font color=\"red\">-4.7%</font>) is down sharply on heavy volume as investors seem to be feeling the weight of the stock's lofty valuation.</li>\n<li>Though it's been a roller coaster ride, shares of Blue Buffalo are still 25% higher than where the company priced the IPO last fall.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188180\" data-linked=\"Valuation concerns perk up again on Blue Buffalo\" data-tweet=\"$BUFF - Valuation concerns perk up again on Blue Buffalo https://seekingalpha.com/news/3188180-valuation-concerns-perk-up-again-on-blue-buffalo?source=tweet\" data-url=\"https://seekingalpha.com/news/3188180-valuation-concerns-perk-up-again-on-blue-buffalo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188179\" data-ts=\"1465500051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMB\" target=\"_blank\">WMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188179-energy-transfer-williams-merger-approved-conditions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer-Williams merger approved with conditions</a></h4><ul>     <li>Williams Cos. (<a href=\"https://seekingalpha.com/symbol/WMB\" title=\"Williams Companies Inc\">WMB</a> <font color=\"green\">+0.7%</font>) is higher and Energy Transfer Equity (ETE <font color=\"red\">-3.3%</font>) is sharply lower after the Federal Trade Commission <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/151-0172/energy-transfer-equitythe-williams-companies-matter\" target=\"_blank\">approves</a> their merger with conditions.</li>     <li>The FTC says the companies must agree to sell WMB's 50% stake in the Gulfstream Natural Gas System, an interstate pipeline that serves Florida, particularly the state's electric power companies.</li>     <li>The merger, originally valued at ~$38B, <a href=\"https://www.thestreet.com/story/13602867/1/williams-cos-wmb-stock-up-ftc-approves-energy-transfer-merger-with-conditions.html\" target=\"_blank\">may not close in H1</a> as scheduled because the agreement with the FTC is subject to a 30-day public comment period, which will end on July 11.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188179\" data-linked=\"Energy Transfer-Williams merger approved with conditions\" data-tweet=\"$WMB $WMB $ET - Energy Transfer-Williams merger approved with conditions https://seekingalpha.com/news/3188179-energy-transfer-williams-merger-approved-conditions?source=tweet\" data-url=\"https://seekingalpha.com/news/3188179-energy-transfer-williams-merger-approved-conditions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188177\" data-ts=\"1465499238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188177-pandora-gains-axiom-upgrades-says-20-buyout-price-seems-reasonable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora gains as Axiom upgrades, says $20+ buyout price &quot;seems reasonable&quot;</a></h4><ul>\n<li>\"Despite the CEO posturing, we believe Pandora's (<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"green\">+2.1%</font>) rich technology, the UI, and the large user base makes it a compelling acquisition even while it is pursuing an on-demand service. A sale could maximize shareholder value quicker,\" writes Axiom Capital's Victor Anthony, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8092639/victor-anthony-upgrades-pandora-to-buy-take-out-price-ab\" target=\"_blank\">upgrading to Buy</a> and setting a $16 target.</li>\n<li>Anthony adds Pandora's core online radio business can further grow ad revenue by increasing ad load, selling more local ads, and using <a href=\"http://marketingland.com/library/display-advertising-news/display-advertising-programmatic-media-buying\" target=\"_blank\">programmatic</a> ad-buying platforms to sell remaining inventory. He also thinks \"there is a greater probability of Pandora building a successful and differentiated on-demand [streaming] service while increasing the value of the core.\"</li>\n<li>Shares are still down moderately YTD, and nearly 70% from a March 2014 peak of $40.44.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188177\" data-linked=\"Pandora gains as Axiom upgrades, says $20+ buyout price &quot;seems reasonable&quot;\" data-tweet=\"$P - Pandora gains as Axiom upgrades, says $20+ buyout price &quot;seems reasonable&quot; https://seekingalpha.com/news/3188177-pandora-gains-axiom-upgrades-says-20-buyout-price-seems-reasonable?source=tweet\" data-url=\"https://seekingalpha.com/news/3188177-pandora-gains-axiom-upgrades-says-20-buyout-price-seems-reasonable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188176\" data-ts=\"1465498847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188176-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SHSP\" title=\"SharpSpring, Inc.\">SHSP</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/GIG\" title=\"GigPeak, Inc.\">GIG</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/ELTK\" title=\"Eltek Ltd.\">ELTK</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/STRM\" title=\"Streamline Health Solutions, Inc.\">STRM</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/BLIN\" title=\"Bridgeline Digital, Inc.\">BLIN</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/HMNY\" title=\"Helios and Matheson Analytics, Inc.\">HMNY</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/RNVA\" title=\"Rennova Health, Inc.\">OTCPK:RNVA</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/CMTL\" title=\"Comtech Telecommunications Corp.\">CMTL</a> <font color=\"red\">-10%</font>. WPCS <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188176\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$SHSP $GIG $ELTK - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3188176-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3188176-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188169\" data-ts=\"1465498599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188169-comtech-telecommunications-slumps-after-posting-mixed-fq3-results-and-2016-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecommunications  slumps after posting mixed FQ3 results and 2016 guidance</a></h4><ul>     <li>In addition to missing FQ3 sales estimates (while beating on EPS) Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) is guiding for FY16 EPS of ($0.90)-($0.80), vs. a consensus of ($1.35).</li>     <li>Revenue of $425M-$430M vs. consensus of $433.41M.</li>     <li>The company revised adjusted EBITDA <strong>downwards</strong> to $44M-$46M vs. $52M-$55M earlier.</li><li>Shares&nbsp;<font color='red'>-9.5%</font>.</li><li><a href=\"https://seekingalpha.com/news/3187968-comtech-telecommunications-beats-0_77-misses-revenue\" target=\"_blank\">Comtech's FQ3 results</a>.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3188169\" data-linked=\"Comtech Telecommunications  slumps after posting mixed FQ3 results and 2016 guidance\" data-tweet=\"$CMTL - Comtech Telecommunications slumps after posting mixed FQ3 results and 2016 guidance https://seekingalpha.com/news/3188169-comtech-telecommunications-slumps-after-posting-mixed-fq3-results-and-2016-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3188169-comtech-telecommunications-slumps-after-posting-mixed-fq3-results-and-2016-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188173\" data-ts=\"1465498470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAY\" target=\"_blank\">PAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188173-standpoint-steps-in-bull-call-on-verifone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Standpoint steps in with bull call on VeriFone</a></h4><ul>\n<li>Standpoint Research buys the dip on VeriFone Systems (NYSE:<a href=\"https://seekingalpha.com/symbol/PAY\" title=\"VeriFone Systems, Inc.\">PAY</a>) with an against-the-grain upgrade to a Buy rating.</li>\n<li>VeriFone is <font color=\"red\">down 0.6%</font> on the day and 20% for the week.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3187789-analysts-sent-scrambling-verifones-outlook-disappoints\" target=\"_blank\">Analysts sent scrambling after VeriFone's outlook disappoints</a> (June 8)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188173\" data-linked=\"Standpoint steps in with bull call on VeriFone\" data-tweet=\"$PAY - Standpoint steps in with bull call on VeriFone https://seekingalpha.com/news/3188173-standpoint-steps-in-bull-call-on-verifone?source=tweet\" data-url=\"https://seekingalpha.com/news/3188173-standpoint-steps-in-bull-call-on-verifone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188172\" data-ts=\"1465498460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOT\" target=\"_blank\">TOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188172-total-says-grandpuits-la-mede-refineries-in-france-running-normally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Total says Grandpuits, La Mede refineries in France running normally</a></h4><ul>     <li>Total (<a href=\"https://seekingalpha.com/symbol/TOT\" title=\"TOTAL S.A.\">TOT</a> <font color=\"red\">-1.6%</font>) says its Grandpuits and La Mede refineries in France are <a href=\"http://af.reuters.com/article/commoditiesNews/idAFL8N19123C\" target=\"_blank\">running normally</a> after striking workers returned to the job, while some striking workers are blocking the full restart of operations at its Donges, Feyzin and Normandy refineries.</li>     <li>Production at the 101K bbl/day Grandpuits refinery near Paris was halted last week after CGT and FO union workers joined a nationwide rolling strike against the French government's plans to reform labor laws.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188172\" data-linked=\"Total says Grandpuits, La Mede refineries in France running normally\" data-tweet=\"$TOT - Total says Grandpuits, La Mede refineries in France running normally https://seekingalpha.com/news/3188172-total-says-grandpuits-la-mede-refineries-in-france-running-normally?source=tweet\" data-url=\"https://seekingalpha.com/news/3188172-total-says-grandpuits-la-mede-refineries-in-france-running-normally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188168\" data-ts=\"1465497785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKUL\" target=\"_blank\">SKUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188168-skullcandy-slips-d-davidson-downgrades-following-wednesdays-surge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skullcandy slips as D.A. Davidson downgrades following Wednesday&#39;s surge</a></h4><ul>\n<li>Though considering a buyout possible, D.A. Davidson's Andrew Burns <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8090782/skullcandy-shares-surge-on-possible-go-private-transacti\" target=\"_blank\">has downgraded</a> Skullcandy (<a href=\"https://seekingalpha.com/symbol/SKUL\" title=\"Skullcandy\">SKUL</a> <font color=\"red\">-2.6%</font>) to Neutral. His target has been hiked by $0.50 to $5.</li>\n<li>Burns notes Skullcandy has underperformed the broader headphone market, and has seen management turnover and margin compression. His downgrade comes a day after shares rose 16% in response to news founder Rick Alden <a href=\"https://seekingalpha.com/news/3187739-founder-rick-alden-wants-take-skullcandy-private-shares-jump\" target=\"_blank\">wants to take Skullcandy private</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188168\" data-linked=\"Skullcandy slips as D.A. Davidson downgrades following Wednesday&#39;s surge\" data-tweet=\"$SKUL - Skullcandy slips as D.A. Davidson downgrades following Wednesday&#39;s surge https://seekingalpha.com/news/3188168-skullcandy-slips-d-davidson-downgrades-following-wednesdays-surge?source=tweet\" data-url=\"https://seekingalpha.com/news/3188168-skullcandy-slips-d-davidson-downgrades-following-wednesdays-surge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188166\" data-ts=\"1465496937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWKS\" target=\"_blank\">SWKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188166-skyworks-slips-on-downgrade-qorvo-upgraded\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skyworks slips on a downgrade; Qorvo upgraded</a></h4><ul>\n<li>Believing the stock \"deserves to trade at a discount or 11x P/E vs. last three year average of 12.5x,\" Citi's Atif Malik <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8092100/citigroup-sell-skyworks-solutions?source=sa\" target=\"_blank\">has downgraded</a> Skyworks (<a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"red\">-1.7%</font>) to Sell, and cut his target by $4.50 to $65.</li>\n<li>Malik notes Skyworks has relatively high exposure to the iPhone 6S, whose sales have been pressured. He also cites a \"lack of premium [RF] filters to address faster growing carrier aggregation market,\" and concerns about \"increasing dual sourcing led competition in the low band market where SWKS participates.\" He could become positive on Skyworks if it makes further progress in lowering its dependence on mobile (still responsible for 80% of sales).</li>\n<li>Rival Qorvo (<a href=\"https://seekingalpha.com/symbol/QRVO\" title=\"Qorvo, Inc\">QRVO</a> <font color=\"red\">-0.4%</font>) has simultaneously been upgraded to Neutral, after \"discussions in Asia indicate improved execution on integration/share gains and higher proliferation of carrier aggregation design wins.\" Malik adds Qorvo gained content share with the Galaxy S7 and iPhone SE. \"Fundamentally, we view carrier aggregation as a key theme for RF stocks with QRVO better positioned to expand its $ growth opportunity based on its comprehensive suite of products including BAW filters.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188166\" data-linked=\"Skyworks slips on a downgrade; Qorvo upgraded\" data-tweet=\"$SWKS $SWKS $QRVO - Skyworks slips on a downgrade; Qorvo upgraded https://seekingalpha.com/news/3188166-skyworks-slips-on-downgrade-qorvo-upgraded?source=tweet\" data-url=\"https://seekingalpha.com/news/3188166-skyworks-slips-on-downgrade-qorvo-upgraded\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188159\" data-ts=\"1465495323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188159-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+19%</font>. URRE <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ASM' title='Avino Silver & Gold Mines Ltd'>ASM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BXE' title='Bellatrix Exploration Ltd'>BXE</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TESO' title='Tesco Corporation'>TESO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188159\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$GBR $EMES $WWR - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3188159-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3188159-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188247\" data-ts=\"1465494569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AM\" target=\"_blank\">AM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188247-antero-midstream-upgraded-baird\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Midstream upgraded at Baird</a></h4><ul>     <li>Antero Midstream Partners (<a href=\"https://seekingalpha.com/symbol/AM\" title=\"Antero Midstream Partners\">AM</a> <font color=\"red\">-2.2%</font>) is lower despite earnings an <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Baird+Upgrades+Antero+Midstream+Partners+LP+%28AM%29+to+Outperform/11724551.html\" target=\"_blank\">upgrade</a> to Outperform from Neutral with a $38 price target, raised from $29, at Baird, which says it gained conviction after meeting with management on AM's long-term volume growth \"which underpins the 30% CAGR in distributions we expect through 2018.\"</li>     <li>Baird believes tightening oil and gas supply in combination with high guidance of volume growth likely will lead to a base case rather than a bear case for AM.</li>     <li>The firm also likes the option AM exercised to purchase a 15% non-operating equity interest in the Stonewall gathering pipeline.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188247\" data-linked=\"Antero Midstream upgraded at Baird\" data-tweet=\"$AM - Antero Midstream upgraded at Baird https://seekingalpha.com/news/3188247-antero-midstream-upgraded-baird?source=tweet\" data-url=\"https://seekingalpha.com/news/3188247-antero-midstream-upgraded-baird\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188154\" data-ts=\"1465492347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188154-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HOMB' title='Home BancShares, Inc.'>HOMB</a> <font color='red'>-51%</font>. AHP <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ITG' title='Investment Technology Group Inc.'>ITG</a> <font color='red'>-9%</font>. FXCM <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3188154\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$HOMB $BHR $ITG - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3188154-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3188154-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188148\" data-ts=\"1465491849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCYX\" target=\"_blank\">SCYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188148-scynexis-lead-product-candidate-underwhelms-in-mid-stage-yeast-infection-study-shares-down-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SCYNEXIS&#39; lead product candidate underwhelms in mid-stage yeast infection study; shares down 24%</a></h4><ul>\n<li>Thinly traded nano cap SCYNEXIS (<a href=\"https://seekingalpha.com/symbol/SCYX\" title=\"SCYNEXIS, Inc.\">SCYX</a> <font color=\"red\">-23.8%</font>) slumps on a 17x surge in volume, albeit on turnover of only 674K shares, in response to its announcement of results from a Phase 2 clinical trial assessing lead product candidate, Fast Track- and QIDP-tagged SCY-078, for the treatment of patients with acute vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.</li>\n<li>The study randomized 96 women with moderate-to-severe VVC 1:1:1 to receive either of two dose regimens of SCY-078 or <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a690002.html\" target=\"_blank\">fluconazole</a>, the standard-of-care prescription oral medication.</li>\n<li>Data from the Intent-to-Treat population all favored SCY-078, but the cure rate, defined by a negative culture, was only slightly better than fluconazole (70.3% versus 68.8%). The therapeutic cure rate, defined as a negative culture and the resolution of symptoms without further antifungal treatment (clinical cure), was identical (56.3%) for both.</li>\n<li>One significant negative was the \"considerably higher rate of GI-related adverse events (diarrhea, nausea, vomiting, abdominal pain) in the SCY-078 arms compared to fluconazole. According to the company, they were \"mild to moderate and transient in nature\" with the majority lasting no more than one day after initiating SCY-078.</li>\n<li>SCY-078 inhibits an enzyme called <a href=\"https://en.wikipedia.org/wiki/1,3-Beta-glucan_synthase\" target=\"_blank\">glucan synthase</a>. Its value proposition is comparable activity to echinocandins [e.g., Astellas' (<a href=\"https://seekingalpha.com/symbol/ALPMF\" title=\"Astellas Pharma, Inc.\">OTCPK:ALPMF</a>)(<a href=\"https://seekingalpha.com/symbol/ALPMY\" title=\"Astellas Pharma, Inc. ADR\">OTCPK:ALPMY</a>) <a href=\"https://www.mycamine.com/\" target=\"_blank\">Mycamine </a>(micafungin sodium) for injection] but available in an oral formulation and active against multi-drug-resistant pathogens, including those resistant to echinocandins.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188148\" data-linked=\"SCYNEXIS&#39; lead product candidate underwhelms in mid-stage yeast infection study; shares down 24%\" data-tweet=\"$SCYX $SCYX $ALPMF - SCYNEXIS&#39; lead product candidate underwhelms in mid-stage yeast infection study; shares down 24% https://seekingalpha.com/news/3188148-scynexis-lead-product-candidate-underwhelms-in-mid-stage-yeast-infection-study-shares-down-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3188148-scynexis-lead-product-candidate-underwhelms-in-mid-stage-yeast-infection-study-shares-down-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188150\" data-ts=\"1465490908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188150-cliffs-natural-to-restart-minnesota-mining-operations-sooner-planned\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural to restart Minnesota mining operations sooner than planned</a></h4><ul>     <li>Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-6.2%</font>) says it will restart operations at its United Taconite division in August, two months earlier than expected.</li>     <li>CLF credits the earlier start to recently contracted business with new client U.S. Steel Canada to supply the majority of their iron ore pellet requirements for Q3 and Q4.</li>     <li>The order prompts CLF to raise its 2016 sales volume guidance to 18M long tons from an earlier outlook for 17.5M long tons and to lift Its production forecast by 500K tons to 16.5M tons.</li>\n<li>CLF had idled its United Taconite and Northshore Mining  operations in Minnesota late last year, citing high levels of steel  imports which hurt demand for its iron ore pellets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188150\" data-linked=\"Cliffs Natural to restart Minnesota mining operations sooner than planned\" data-tweet=\"$CLF - Cliffs Natural to restart Minnesota mining operations sooner than planned https://seekingalpha.com/news/3188150-cliffs-natural-to-restart-minnesota-mining-operations-sooner-planned?source=tweet\" data-url=\"https://seekingalpha.com/news/3188150-cliffs-natural-to-restart-minnesota-mining-operations-sooner-planned\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188149\" data-ts=\"1465490674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188149-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/JAGX\" title=\"Jaguar Animal Health, Inc.\">JAGX</a> <font color=\"green\">+92%</font>. <a href=\"https://seekingalpha.com/symbol/BLPH\" title=\"Bellerophon Therapeutics\">BLPH</a> <font color=\"green\">+61%</font>. <a href=\"https://seekingalpha.com/symbol/GBR\" title=\"New Concept Energy, Inc.\">GBR</a> <font color=\"green\">+34%</font>. <a href=\"https://seekingalpha.com/symbol/CLRB\" title=\"Cellectar Biosciences, Inc.\">CLRB</a> <font color=\"green\">+20%</font>. URRE <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/STAF\" title=\"Staffing 360 Solutions, Inc.\">STAF</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/ONTX\" title=\"Onconova Therapeutics\">ONTX</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CRTN\" title=\"Cartesian, Inc.\">OTC:CRTN</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/CBK\" title=\"Christopher &amp; Banks Corporation\">CBK</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/ASM\" title=\"Avino Silver &amp; Gold Mines Ltd\">ASM</a> <font color=\"green\">+12%</font>.</li>\n<li>\n<b>Losers: </b><a href=\"https://seekingalpha.com/symbol/HIIQ\" title=\"Health Insurance Innovations\">HIIQ</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/SCYX\" title=\"SCYNEXIS, Inc.\">SCYX</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/TLRD\" title=\"Tailored Brands, Inc\">TLRD</a> <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/IMMU\" title=\"Immunomedics, Inc.\">IMMU</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/BLIN\" title=\"Bridgeline Digital, Inc.\">BLIN</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/STS\" title=\"Supreme Industries, Inc\">STS</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/RGSE\" title=\"RGS Energy, Inc.\">RGSE</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/EAC\" title=\"Erickson Air-Crane\">EAC</a> <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188149\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$JAGX $BLPH $GBR - Midday Gainers / Losers https://seekingalpha.com/news/3188149-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3188149-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188146\" data-ts=\"1465489753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRG\" target=\"_blank\">NRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188146-nrg-energy-downgraded-to-sell-from-buy-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NRG Energy downgraded to Sell from Buy at UBS</a></h4><ul>     <li>NRG Energy (<a href=\"https://seekingalpha.com/symbol/NRG\" title=\"NRG Energy, Inc.\">NRG</a> <font color=\"red\">-7.5%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/06/09/nrg-energy-now-thats-a-downgrade/?mod=BOL_hp_blog_stw\" target=\"_blank\">downgraded to Sell from Buy</a> with a $16 price target at UBS, which says the stock's risk and reward \"skews negatively\" following the near doubling off January lows.</li>     <li>\"NRG and peers have rallied as part of a bullish gas thesis, but we think the market is overlooking the $285M decrease in PJM capacity revenue and the potential for continued weakness in PJM, which represents 33% of capacity,\u201d UBS writes.</li>     <li>Despite NRG\u2019s strong performance YTD, 2019 ATC power prices are roughly flat in its core markets and the recent PJM capacity auction came in solidly below expectations, and UBS notes that PJM deterioration is particularly negative for NRG as it looks to negotiate with creditors of its GenOn subsidiary.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188146\" data-linked=\"NRG Energy downgraded to Sell from Buy at UBS\" data-tweet=\"$NRG - NRG Energy downgraded to Sell from Buy at UBS https://seekingalpha.com/news/3188146-nrg-energy-downgraded-to-sell-from-buy-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3188146-nrg-energy-downgraded-to-sell-from-buy-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188142\" data-ts=\"1465489188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLPH\" target=\"_blank\">BLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188142-bellerophon-up-over-70-on-big-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellerophon up over 70% on big volume</a></h4><ul>\n<li>Bellerophon Therapeutics (<a href=\"https://seekingalpha.com/symbol/BLPH\" title=\"Bellerophon Therapeutics\">BLPH</a> <font color=\"green\">+73.1%</font>) rockets up on a whopping 210x surge in volume. No particular news accounts for the move, but this is yet another recent price spike in the biotech nano cap space.</li>\n<li>Recent up moves include: Immune Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IMNP\" title=\"Immune Pharmaceuticals Inc.\">OTCQB:IMNP</a> <font color=\"red\">-2.5%</font>), Jaguar Animal Health (<a href=\"https://seekingalpha.com/symbol/JAGX\" title=\"Jaguar Animal Health, Inc.\">JAGX</a> <font color=\"green\">+89.4%</font>), Biostar Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"red\">-23.4%</font>) and Cyclacel Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"red\">-0.6%</font>).</li>\n<li>The action may be attractive to some, but these types of moves are notorious for quick round-trips.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188142\" data-linked=\"Bellerophon up over 70% on big volume\" data-tweet=\"$BLPH $BLPH $IMNPQ - Bellerophon up over 70% on big volume https://seekingalpha.com/news/3188142-bellerophon-up-over-70-on-big-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3188142-bellerophon-up-over-70-on-big-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188132\" data-ts=\"1465486915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188132-barrick-gold-is-lowest-cost-producer-survey-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick Gold is lowest-cost producer, survey says</a></h4><ul>     <li>Barrick Gold (ABX <font color=\"green\">+1.5%</font>) had the <a href=\"http://www.mining-journal.com/financeinvestment/production/barrick-is-lowest-cost-gold-producer/\" target=\"_blank\">lowest all-in sustaining cost during Q1</a> at $706/oz., $130 less than the group median of $836/oz., according to a report compiled by SNL Metals &amp; Mining.</li>     <li>ABX benefited mostly from operating and capital cost control initiatives, and from lower fuel prices and foreign exchange gains, SNL says.</li>     <li>Northern Star Resources (<a href=\"https://seekingalpha.com/symbol/NESRF\" title=\"Northern Star Resources Ltd\">OTCPK:NESRF</a>) and Newcrest Mining (<a href=\"https://seekingalpha.com/symbol/NCMGF\" title=\"Newcrest Mining Ltd.\">OTCPK:NCMGF</a>) came in slightly behind ABX with AISC of $711/oz. and $723/oz., respectively.</li>     <li>At the other end of the scale, Iamgold (NYSE:<a href=\"https://seekingalpha.com/symbol/IAG\" title=\"IAMGOLD Corporation\">IAG</a>) reported the highest AISC at $1,084/oz., followed by Centerra Gold (<a href=\"https://seekingalpha.com/symbol/CAGDF\" title=\"Centerra Gold Inc.\">OTCPK:CAGDF</a>) and Gold Fields (NYSE:<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a>), with respective AISC of $1,015/oz. and $961/oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188132\" data-linked=\"Barrick Gold is lowest-cost producer, survey says\" data-tweet=\"$GOLD $GOLD $NESRF - Barrick Gold is lowest-cost producer, survey says https://seekingalpha.com/news/3188132-barrick-gold-is-lowest-cost-producer-survey-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3188132-barrick-gold-is-lowest-cost-producer-survey-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188127\" data-ts=\"1465485841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188127-chesapeakeminus-6_7-rbc-downgrades-on-looming-leverage-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake -6.7% as RBC downgrades on looming leverage concerns</a></h4><ul>     <li>Chesapeake Energy (<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"red\">-6.7%</font>) is <a href=\"http://realmoney.thestreet.com/articles/06/09/2016/stressed-out-chesapeake-energy-slips-rbc-downgrade-over-looming-debt\" target=\"_blank\">downgraded</a> to Underperform from Sector Perform with a $5 price target at RBC Capital, mostly on concerns about $2.2B in looming debt maturities.</li>     <li>The firm also notes that CHK has another $1B in debt coming due in 2019 and again in 2020, so much-needed free cash flow could be scarce over the two-year period.</li>     <li>CHK closed a $385M sale of oil and gas assets this month tied to the western Anadarko Basin, but RBC says the company would be better off selling more of its acreage to shore up cash, pointing to the 42K acres recently sold for $470M.</li>     <li>RBC also cites valuation in its downgrade, as well as its view that CHK's opportunities to add value in a rising commodity market are more limited than its peers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188127\" data-linked=\"Chesapeake -6.7% as RBC downgrades on looming leverage concerns\" data-tweet=\"$CHK - Chesapeake -6.7% as RBC downgrades on looming leverage concerns https://seekingalpha.com/news/3188127-chesapeakeminus-6_7-rbc-downgrades-on-looming-leverage-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3188127-chesapeakeminus-6_7-rbc-downgrades-on-looming-leverage-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188123\" data-ts=\"1465484767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/E\" target=\"_blank\">E</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188123-eni-bp-find-egyptian-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eni, BP find more Egyptian gas</a></h4><ul>     <li>Eni (<a href=\"https://seekingalpha.com/symbol/E\" title=\"ENI S.p.A.\">E</a> <font color=\"red\">-1.6%</font>) and BP (<a href=\"https://seekingalpha.com/symbol/BP\" title=\"BP p.l.c.\">BP</a> <font color=\"red\">-0.9%</font>) say they made a <a href=\"http://www.bloomberg.com/news/articles/2016-06-09/egypt-is-gift-that-keeps-on-giving-as-eni-bp-find-more-gas\" target=\"_blank\">significant natural gas discovery</a> off the Egyptian coast, adding to a series of finds in the region in the last year.</li>\n<li>Eni, the operator, and BP each hold a 50% stake in the Baltim South exploration project in the Nile Delta.</li>     <li>The discovery is 10 km from the Nooros field, which already is pumping 65K boe/day.</li>     <li>Today\u2019s news is \u201cpositive given unsatiated domestic gas demand\u201d in Egypt, according to Tudor Pickering Holt.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3188123\" data-linked=\"Eni, BP find more Egyptian gas\" data-tweet=\"$E $E $BP - Eni, BP find more Egyptian gas https://seekingalpha.com/news/3188123-eni-bp-find-egyptian-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/3188123-eni-bp-find-egyptian-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188108\" data-ts=\"1465484732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188108-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+94%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+83%</font>. <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/EVHC' title='Envision Healthcare Holdings'>EVHC</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3188108\" data-linked=\"Healthcare - Top 5 Gainers / losers as of 11:00 am\" data-tweet=\"$JAGX $BLPH $OPGN - Healthcare - Top 5 Gainers / losers as of 11:00 am https://seekingalpha.com/news/3188108-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3188108-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188122\" data-ts=\"1465484643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188122-fitbit-gains-after-bullish-wedbush-coverage-upbeat-conference-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit gains after bullish Wedbush coverage, upbeat conference reports</a></h4><ul>\n<li>\"We believe that Fitbit (<a href=\"https://seekingalpha.com/symbol/FIT\" title=\"Fitbit, Inc.\">FIT</a> <font color=\"green\">+2.5%</font>) shares are currently undervalued given a long runway remaining from an installed base perspective, as well as relatively untapped accessory, co-branding, and corporate wellness opportunities,\" writes Wedbush's Nick McKay, <a href=\"http://www.streetinsider.com/Analyst+Comments/Wedbush+Sees+Long+Runway+for+Growth+at+Fitbit+%28FIT%29%3B+Coverage+Initiated+at+Outperform/11723334.html\" target=\"_blank\">launching coverage</a> with an Outperform rating and $18 target. \"We believe that these positive factors outweigh the risk of commoditization over the next few years and a seemingly slowing pace of technological innovation.\"</li>\n<li>He also downplays commoditization fears, arguing Fitbit's brand and the willingness of consumers \"to spend more on a product that relates to monitoring their health\" will help it fend off rivals. His target is equal to 12x a 2017 EPS estimate of $1.50.</li>\n<li>The company has also received bullish notes from <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8092262/fitbit-citigroup-reiterates-buy-on-corporate-wellness?source=sa\" target=\"_blank\">Citi</a>, <a href=\"http://www.streetinsider.com/Analyst+Comments/FitBit+%28FIT%29+Wellness+Summit+Day+1+Takeaways+-+Dougherty+%26+Co./11720580.html\" target=\"_blank\">Dougherty</a>, and <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8089028/bob-pecks-5-takeaways-from-fitbits-captivate-summit\" target=\"_blank\">SunTrust</a> after the firms attended Fitbit's corporate wellness-focused Captivate summit. Dougherty reports 52% of Target employees (~187K) obtained a Fitbit following Target's 2015 deal with the company, and notes direct sales to corporate buyers carry higher margins than sales to retailers.</li>\n<li>Citi: \"Although Fitbit has 70 Fortune 500 customers and 1,000 total corporate customers, the corporate opportunity remains a nascent one, currently accounting for &lt;10 percent of total revenue. SunTrust: \"In our view, there are only a handful of fitness device and smartwatch manufacturers that can match Fitbit on its product range, battery lives, software capabilities, ecosystem effect (43 million devices sold to date), data security, and integration with third-party apps. Consequently, we think Fitbit may be able to maintain its competitive advantage within the corporate wellness market over the near- to mid-term.\"</li>\n<li>The analyst notes arrive two days after Fitbit announced a Group Health solution for corporate and healthcare clients that brings together various existing offerings, and an analytics services measuring the performance of corporate wellness investments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188122\" data-linked=\"Fitbit gains after bullish Wedbush coverage, upbeat conference reports\" data-tweet=\"$FIT - Fitbit gains after bullish Wedbush coverage, upbeat conference reports https://seekingalpha.com/news/3188122-fitbit-gains-after-bullish-wedbush-coverage-upbeat-conference-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3188122-fitbit-gains-after-bullish-wedbush-coverage-upbeat-conference-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188117\" data-ts=\"1465483919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AI\" target=\"_blank\">AI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188117-arlington-asset-investment-wins-proxy-battle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arlington Asset Investment wins proxy battle</a></h4><ul>\n<li>Based on a preliminary vote count, Arlington's (<a href=\"https://seekingalpha.com/symbol/AI\" title=\"Arlington Asset Investment Corporation\">AI</a> <font color=\"red\">-1.3%</font>) slate of nominees have been \"overwhelmingly\" elected to the board, among them CEO J. Rock Tonkel.</li>\n<li>Working with the Clinton Group, Imation Corp. (IMN) had <a href=\"https://seekingalpha.com/news/3172144-activist-campaign-arlington-asset\" target=\"_blank\">nominated</a> its own slate for the board.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188117\" data-linked=\"Arlington Asset Investment wins proxy battle\" data-tweet=\"$AI $AI $GLA - Arlington Asset Investment wins proxy battle https://seekingalpha.com/news/3188117-arlington-asset-investment-wins-proxy-battle?source=tweet\" data-url=\"https://seekingalpha.com/news/3188117-arlington-asset-investment-wins-proxy-battle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188115\" data-ts=\"1465483462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSY\" target=\"_blank\">HSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188115-hershey-higher-on-megachocolate-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hershey higher on MegaChocolate talk</a></h4><ul> <li>Shares of Hershey (NYSE:<a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a>)&nbsp;are <font color='green'>up 1.7%</font> with some traders chatting up a Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>, <a href='https://seekingalpha.com/symbol/NSRGF' title='Nestle S.A.'>OTCPK:NSRGF</a>) buyout scenario.</li> <li>Nestle is currently third in the North America chocolate market behind Hershey and Mars.</li> <li>A Nestle-Hershey combination would likely lead to some asset sales, similar to the MegaBrew deal maneuvers that Anheuser-Busch InBev and SABMiller had to work out to appease regulators.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188115\" data-linked=\"Hershey higher on MegaChocolate talk\" data-tweet=\"$HSY $HSY $NSRGY - Hershey higher on MegaChocolate talk https://seekingalpha.com/news/3188115-hershey-higher-on-megachocolate-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3188115-hershey-higher-on-megachocolate-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188111\" data-ts=\"1465483077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188111-tailored-brands-slides-after-earnings-misfire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tailored Brands slides after earnings misfire</a></h4><ul> <li>Tailored Brands (<a href=\"https://seekingalpha.com/symbol/TLRD\" title=\"Tailored Brands, Inc\">TLRD</a> <font color=\"red\">-16.2%</font>) is sharply lower after FQ1 results miss estimates by a wide margin.</li> <li>The company pointed to improved results in May during the post-earnings conference call.</li> <li>\"We are making progress on our transition plan for Tailored Brands,\" said CEO Doug Ewert. However, investors have their eyes on TLRD's margin rates which shrunk in FQ1.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3187969-tailored-brands-misses-0_16-misses-revenue\" target=\"_blank\">Tailored Brands misses by $0.16, misses on revenue</a> (June 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188111\" data-linked=\"Tailored Brands slides after earnings misfire\" data-tweet=\"$TLRD - Tailored Brands slides after earnings misfire https://seekingalpha.com/news/3188111-tailored-brands-slides-after-earnings-misfire?source=tweet\" data-url=\"https://seekingalpha.com/news/3188111-tailored-brands-slides-after-earnings-misfire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188103\" data-ts=\"1465482301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAT\" target=\"_blank\">EAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188103-brinker-internationalplus-5-after-updating-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brinker International +5% after updating guidance</a></h4><ul> <li>Brinker International (NYSE:<a href=\"https://seekingalpha.com/symbol/EAT\" title=\"Brinker International, Inc.\">EAT</a>) announces new guidance just ahead of today's analyst day event.</li>\n<li>The company continues to expect FY16 EPS to be near the low end of the original guidance range of $3.55 to $3.65. The consensus estimate on Wall Street is $3.53.</li>\n<li>FQ4 comparable restaurant sales are expected to improve from FQ3 results, although remain in negative territory.</li>\n<li>As of June 2, quarter-to-date company-owned comparable restaurant sales were down 2% which includes decreases for both Chili's and Maggiano's company-owned restaurants.</li>\n<li>FY17 earnings EPS of $3.40 to $3.50 is anticipated vs. $3.47 consensus.</li>   <li>\"We are encouraged by the quarter-to-date progress of our brands,\" said CEO Wyman Roberts</li>\n<li>EAT is <font color=\"green\">+5.136%</font>  to $47.49</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188103\" data-linked=\"Brinker International +5% after updating guidance\" data-tweet=\"$EAT - Brinker International +5% after updating guidance https://seekingalpha.com/news/3188103-brinker-internationalplus-5-after-updating-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3188103-brinker-internationalplus-5-after-updating-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188100\" data-ts=\"1465481861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBR\" target=\"_blank\">KBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188100-kbr-wins-185m-extension-to-manage-qatars-expressway-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KBR wins $185M extension to manage Qatar&#39;s Expressway Program</a></h4><ul>     <li>KBR (<a href=\"https://seekingalpha.com/symbol/KBR\" title=\"KBR, Inc.\">KBR</a> <font color=\"red\">-1.8%</font>) says it has been awarded an extension, valued in excess of $185M, to its program management consultant contract for Qatar's Expressway Program.</li>     <li>KBR says it is responsible for overseeing supervision consultants, design consultants and construction contractors for this program of both new roads and road network upgrades.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188100\" data-linked=\"KBR wins $185M extension to manage Qatar&#39;s Expressway Program\" data-tweet=\"$KBR - KBR wins $185M extension to manage Qatar&#39;s Expressway Program https://seekingalpha.com/news/3188100-kbr-wins-185m-extension-to-manage-qatars-expressway-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3188100-kbr-wins-185m-extension-to-manage-qatars-expressway-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188089\" data-ts=\"1465480109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188089-cnbc-bids-above-5b-for-yahoos-core-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Bids above $5B for Yahoo&#39;s core business</a></h4><ul><li>CNBC's David Faber reports Yahoo (YHOO <font color='green'>+1.1%</font>) as having received multiple bids <a href=\"http://www.cnbc.com/2016/06/09/yahoo-has-received-multiple-bids.html\" target=\"_blank\">above $5B for</a> its core business. That would place Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> flat) - which is reported to have offered in the area of $3.5B - among the lower end of bidders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3188089\" data-linked=\"CNBC: Bids above $5B for Yahoo&#39;s core business\" data-tweet=\"$AABA $AABA $VZ - CNBC: Bids above $5B for Yahoo&#39;s core business https://seekingalpha.com/news/3188089-cnbc-bids-above-5b-for-yahoos-core-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3188089-cnbc-bids-above-5b-for-yahoos-core-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188073\" data-ts=\"1465478083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMPH\" target=\"_blank\">KMPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188073-kempharm-files-request-for-amendment-to-apadaz-nda-todays-action-date-postponed-shares-slump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KemPharm files request for amendment to Apadaz NDA, today&#39;s action date postponed; shares slump 19% premarket</a></h4><ul>\n<li>KemPharm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KMPH\" title=\"KemPharm\">KMPH</a>) is down <font color=\"red\">19%</font> premarket on modest volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1434647/000156459016020407/kmph-ex991_6.htm\" target=\"_blank\">announcement</a> that it has filed a request with the FDA to amend its New Drug Application (NDA) seeking approval of <a href=\"http://www.kempharm.com/pages/pipeline/pain.php\" target=\"_blank\">Apadaz </a>(benzhydrocodone hydrochloride and acetaminophen) for the short-term management of acute pain. The company says it wants to include additional information that will strengthen the labeling. The action will likely push the agency's action date out at least six months.</li>\n<li>Last month, FDA Advisory Committees voted 16-4 backing approval but 18-2 against abuse-deterrent labeling.</li>\n<li>Apadaz was developed using the company's proprietary <a href=\"http://www.kempharm.com/pages/technology/index.php\" target=\"_blank\">Ligand-Activated Technology</a> (LAT) which creates a prodrug by chemically attaching one or more molecules (ligands) to the parent drug which inactivates it. Once inside the body, the ligand separates from the parent drug which then enables it to deliver its therapeutic effect. In terms of opioids, the company has positioned LAT as abuse-deterrent technology since it limits excessive exposure compared to currently available products like Vicodin, Norco and Lortab.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188073\" data-linked=\"KemPharm files request for amendment to Apadaz NDA, today&#39;s action date postponed; shares slump 19% premarket\" data-tweet=\"$KMPH - KemPharm files request for amendment to Apadaz NDA, today&#39;s action date postponed; shares slump 19% premarket https://seekingalpha.com/news/3188073-kempharm-files-request-for-amendment-to-apadaz-nda-todays-action-date-postponed-shares-slump?source=tweet\" data-url=\"https://seekingalpha.com/news/3188073-kempharm-files-request-for-amendment-to-apadaz-nda-todays-action-date-postponed-shares-slump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188071\" data-ts=\"1465477888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188071-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/ACUR' title='Acura Pharmaceuticals, Inc.'>OTC:ACUR</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/EVHC' title='Envision Healthcare Holdings'>EVHC</a> <font color='green'>+9%</font>. MCUR <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm'>KMPH</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/INSM' title='Insmed, Inc.'>INSM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TESO' title='Tesco Corporation'>TESO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3188071\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$JAGX $ACUR $SUNW - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3188071-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3188071-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188033\" data-ts=\"1465476818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVET\" target=\"_blank\">NVET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188033-nexvet-presents-expanded-positive-clinical-data-for-nvminus-01-and-nvminus-02-acvim-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nexvet presents expanded positive clinical data for NV-01 and NV-02 at ACVIM; shares up 17% premarket</a></h4><ul> <li>Nexvet Biopharma (<a href=\"https://seekingalpha.com/symbol/NVET\" title=\"Nexvet Biopharma\">NVET</a> <font color=\"green\">+17%</font>) presented expanded results regarding completed clinical studies for ranevetmab (or \u201cNV-01\u201d) and frunevetmab (or \u201cNV-02\u201d) to veterinarians and veterinary key opinion leaders at a Nexvet-hosted seminar at the American College of Veterinary Internal Medicine (ACVIM) Forum in Denver, Colorado. Ranevetmab and frunevetmab are anti-nerve growth factor (NGF) monoclonal antibody therapies in development as monthly subcutaneous injectables for the control of pain associated with osteoarthritis in dogs and cats, respectively.</li>       <li>Ranevetmab (NV-01) pivotal efficacy and field safety study states dogs treated NV-02 showed statistically significant improvement and reduction in assessed level of pain measured using CSOM from enrollment to day 28, day 56 and day 84. Assessment was also carried out using CBPI treatment from enrollment to day 14, day 28 and day 56.</li>\n<li>Frunevetmab (NV-02) pilot field study states cats treated with NV-02 showed  significant improvement and reduction in pain using CSOM and FMPI both from enrollment  to day 42 and day 56.</li>\n<li>There was also statistically significant difference between ranevetmab-treated dogs and placebo on day 28 and frunevetmab-treated cats and placebo on day 28 and day 56.</li>       <li>Nexvet intends to file further regulatory submissions and initiate the pivotal target animal safety study for ranevetmab and  frunevetmab in 2016.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188033\" data-linked=\"Nexvet presents expanded positive clinical data for NV-01 and NV-02 at ACVIM; shares up 17% premarket\" data-tweet=\"$NVET - Nexvet presents expanded positive clinical data for NV-01 and NV-02 at ACVIM; shares up 17% premarket https://seekingalpha.com/news/3188033-nexvet-presents-expanded-positive-clinical-data-for-nvminus-01-and-nvminus-02-acvim-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3188033-nexvet-presents-expanded-positive-clinical-data-for-nvminus-01-and-nvminus-02-acvim-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188064\" data-ts=\"1465476539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSM\" target=\"_blank\">INSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188064-insmed-withdraws-arikayce-marketing-application-in-europe-shares-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insmed withdraws Arikayce marketing application in Europe; shares down 13% premarket</a></h4><ul>\n<li>Insmed (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a>) is off <font color=\"red\">13%</font> premarket on light volume in response to its announcement that it has withdrawn its Marketing Authorization Application (MAA) in Europe seeking approval of lead product candidate <a href=\"http://www.insmed.com/about-arikayce/\" target=\"_blank\">ARIKAYCE </a>(Liposomal Amikacin for Inhalation) for the treatment of nontuberculous mycobacteria lung disease.</li>\n<li>The company took action after a thumbs down from the Committee for Medicinal Products for Human Use (CHMP) in May stating its Phase 2 study failed to provide sufficient evidence to support approval. Insmed says it will resubmit the MAA when results from its ongoing Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02344004?term=insmed&amp;phase=2&amp;rank=2\" target=\"_blank\">CONVERT</a>, are available. According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoint is October.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188064\" data-linked=\"Insmed withdraws Arikayce marketing application in Europe; shares down 13% premarket\" data-tweet=\"$INSM - Insmed withdraws Arikayce marketing application in Europe; shares down 13% premarket https://seekingalpha.com/news/3188064-insmed-withdraws-arikayce-marketing-application-in-europe-shares-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3188064-insmed-withdraws-arikayce-marketing-application-in-europe-shares-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188059\" data-ts=\"1465475707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188059-seadrill-to-make-another-debt-for-equity-exchange\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill to make another debt-for-equity exchange</a></h4><ul>     <li>Seadrill (NYSE:<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a>) <font color=\"red\">-4.1%</font> premarket following news that it will make a <a href=\"http://www.seadrill.com/investor-relations/news/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/S/135817/PR/201606/2019221.xml\" target=\"_blank\">second bond swap</a> in a month to help trim its debt load.</li>     <li>SDRL says it will issue 7.5M new common shares with par value of $2/share to some holders of its bonds due September 2017, in exchange for $50M of debt principal; SDRL completed a similar deal, worth $55M, <a href=\"https://seekingalpha.com/news/3184157-seadrill-moves-higher-debt-equity-deal\" target=\"_blank\">last month</a>.</li>     <li>The new deal implies a bond price of $0.5475 on the dollar, a 3.8% premium to yesterday\u2019s closing price, Nordea Bank says.</li>     <li>SDRL has the equivalent of more than $3.7B of debt <a href=\"http://www.bloomberg.com/news/articles/2016-06-09/seadrill-will-make-second-bond-swap-in-a-month-to-trim-debt-load\" target=\"_blank\">due for repayment by the end of 2017</a>, according to Bloomberg.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188059\" data-linked=\"Seadrill to make another debt-for-equity exchange\" data-tweet=\"$SDRL - Seadrill to make another debt-for-equity exchange https://seekingalpha.com/news/3188059-seadrill-to-make-another-debt-for-equity-exchange?source=tweet\" data-url=\"https://seekingalpha.com/news/3188059-seadrill-to-make-another-debt-for-equity-exchange\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188041\" data-ts=\"1465473540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPG\" target=\"_blank\">WPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188041-reuters-kite-realty-and-wp-glimcher-in-merger-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Kite Realty and WP Glimcher in merger talks</a></h4><ul>\n<li>WP Glimcher (NYSE:<a href=\"https://seekingalpha.com/symbol/WPG\" title=\"Washington Prime Group, Inc.\">WPG</a>) shot higher in late action yesterday <a href=\"http://www.reuters.com/article/us-wpglimcher-m-a-kiterealty-exclusive-idUSKCN0YU2IG\" target=\"_blank\">on a report its in sale talks</a> with Kite Realty Group (NYSE:<a href=\"https://seekingalpha.com/symbol/KRG\" title=\"Kite Realty Group Trust\">KRG</a>). Both are similarly sized, with KRG at a $2.3B market cap, and WPG at $2B.</li>\n<li>Kite is no stranger to acquisitions, having purchased Inland Diversified Real Estate Trust in 2014 for $1.2B. WP Glimcher is the product of Washington Prime Group's $2B purchase of Glimcher Realty Trust last year. Washington Prime was spun out of Simon Property Group in 2014. These guys know how to keep their bankers happy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188041\" data-linked=\"Reuters: Kite Realty and WP Glimcher in merger talks\" data-tweet=\"$WPG $WPG $KRG - Reuters: Kite Realty and WP Glimcher in merger talks https://seekingalpha.com/news/3188041-reuters-kite-realty-and-wp-glimcher-in-merger-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3188041-reuters-kite-realty-and-wp-glimcher-in-merger-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188037\" data-ts=\"1465473028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188037-solarcityplus-5-on-baird-upgrade-says-regulatory-worries-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarCity +5% on Baird upgrade; says regulatory worries overdone</a></h4><ul>\n<li>SolarCity (SCTY) <font color=\"green\">+4.9%</font> premarket after Baird <a href=\"http://www.marketwatch.com/story/solarcitys-stock-surges-after-rw-baird-upgrade-2016-06-09\" target=\"_blank\">upgrades shares to Outperform</a> from Neutral with a $37 target price on the belief that investors may have overreacted to concerns over regulatory issues, such  as NV Energy's recent decision to cut net metering benefits.</li>\n<li>The firm notes that SCTY  recently announced multiple financing transactions, which should help  ease concerns over the company's balance sheet and access to liquidity, and it anticipates further project  cost reductions to open new markets.</li>\n<li>Also, Baird believes potential module  oversupply could help SCTY reduce system costs in H2.</li>\n<li>\"We believe negative sentiment is overdone on one of the leading U.S.  rooftop installers, and think shares are attractive at current levels,\" Baird writes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188037\" data-linked=\"SolarCity +5% on Baird upgrade; says regulatory worries overdone\" data-tweet=\"$TSLA - SolarCity +5% on Baird upgrade; says regulatory worries overdone https://seekingalpha.com/news/3188037-solarcityplus-5-on-baird-upgrade-says-regulatory-worries-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3188037-solarcityplus-5-on-baird-upgrade-says-regulatory-worries-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188036\" data-ts=\"1465472749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAN\" target=\"_blank\">FRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188036-on-francescas-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Francesca&#39;s Q1</a></h4><ul>     <li>Francesca's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FRAN\" title=\"Francesca's Holdings Corp.\">FRAN</a>) reports comparable-store sales rose 2% in Q1 driven by an increase in the number of transactions both at the boutiques and on-line.</li>     <li>Ecommerce comparable sales increased 38% for the period.</li>     <li>Merchandise category sales: Apparel: $54.89M (+14%); Jewelry: $24.06M (+10%); Accessories: $16.05M (+4%); Gifts and home: $11.33M (+15%).</li>     <li>Gross margin rate decreased 100 bps to 46.3%.</li>     <li>SG&amp;A expense rate expanded 80 bps to 35.5%.</li>     <li>Operating margin rate dropped 170 bps to 10.8%.</li>     <li>Inventory +10.8% Y/Y to $34.8M.</li>     <li>Boutique count +30 Q/Q to 646.</li>     <li>\n<b>Q2 Guidance</b>: Net sales: $106M to $110M; Comparable-store sales: mid-single digit decrease; EPS: $0.16 to $0.19; New boutiques: 15 to 20.</li>     <li>\n<b>FY2016 Guidance</b>: Net sales: $460M to $480M; Comparable-store sales: flat to a low-single digit decrease; EPS: $0.86 to $0.96; Shares outstanding: 39.6M; Tax rate: 37.8%; Capital expenditure: $28M to $31M; New boutiques: 50 to 60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188036\" data-linked=\"More on Francesca&#39;s Q1\" data-tweet=\"$FRAN - More on Francesca&#39;s Q1 https://seekingalpha.com/news/3188036-on-francescas-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3188036-on-francescas-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188035\" data-ts=\"1465472700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188035-analysts-reset-on-restoration-hardware-after-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts do a reset on Restoration Hardware after weak guidance</a></h4><ul> <li>Telsey Advisory Group <a href=\"https://www.briefing.com/Investor/PopupPages/ArticlePopup.aspx?ArticleId=UD20160609072634\" target=\"_blank\">lowers</a> Restoration Hardware (NYSE:<a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a>) to a Market Perform rating after bailing on its Outperform stance.</li> <li>The investment firm whacks the price target on the retailer by 39% to $30.</li> <li>Growing pains for the RH Modern concept factored into Restoration Hardware's drop in guidance yesterday.</li>\n<li>Other rating cuts: Raymond James (Market Perform), Deutsche Bank (Hold), and Longbow Research (Neutral).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3187947-soft-guidance-hits-restoration-hardware\" target=\"_blank\">Soft guidance hits Restoration Hardware</a> (June 8)</li> <li>RH <font color=\"red\">-19.02%</font> premarket to $29.20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188035\" data-linked=\"Analysts do a reset on Restoration Hardware after weak guidance\" data-tweet=\"$RH - Analysts do a reset on Restoration Hardware after weak guidance https://seekingalpha.com/news/3188035-analysts-reset-on-restoration-hardware-after-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3188035-analysts-reset-on-restoration-hardware-after-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188034\" data-ts=\"1465472622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188034-premarket-move-for-linkedin-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket move for LinkedIn after upgrade</a></h4><ul>\n<li>Calling the company well-positioned to take advantage of a number of large recruitment and advertising markets, <a href=\"http://www.streetinsider.com/Analyst+Comments/RBC+Capital+Upgrades+LinkedIn+%28LNKD%29+to+Outperform/11723590.html\" target=\"_blank\">RBC Capital's Mark Mahaney</a> upgrades LinkedIn (LNKD) to Outperform from Sector Perform. The big drop in the stock price this year (though it has rallied more than 30% from the lows) makes the valuation \"reasonably attractive.\"</li>\n<li>His $160 price target compares to yesterday's close of $133.84. Shares are <font color=\"green\">up 2.6%</font> premarket to $137.30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3188034\" data-linked=\"Premarket move for LinkedIn after upgrade\" data-tweet=\"$MSFT - Premarket move for LinkedIn after upgrade https://seekingalpha.com/news/3188034-premarket-move-for-linkedin-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3188034-premarket-move-for-linkedin-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188027\" data-ts=\"1465471394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJM\" target=\"_blank\">SJM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188027-on-j-m-smuckers-fq4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.M. Smucker&#39;s FQ4</a></h4><ul>     <li>J.M. Smucker (NYSE:<a href=\"https://seekingalpha.com/symbol/SJM\" title=\"J. M. Smucker Company\">SJM</a>) reports net sales rose 25% in FQ4 reflecting the contribution of Big Heart Pet Brands and growth within the U.S. retail coffee segment.</li>     <li>Excluding acquisitions and foreign currency exchange net sales expanded 5%.</li>     <li>Revenue by segment: U.S. Retail Coffee: $512.6M (+9%); U.S. Retail Consumer Foods: $473.7M (-2%); U.S. Retail Pet Foods: $562.9M; International and Foodservice: $258.4M (-1%).</li>     <li>Adjusted gross margin rate improved 590 bps to 37.7%.</li>     <li>Total SD&amp;A expenses rate fell 40 bps to 19.5%.</li>     <li>Adjusted operating margin rate grew 590 bps to 15.5%.</li>     <li>EBITDA margin was 19.8% vs -1.5% in 4Q15.</li>     <li>\n<b>FY2017 Guidance</b>: Net sales: -1% Y/Y; Diluted EPS: $5.85 to $6; Adjusted non-GAAP EPS: $7.60 - $7.75; Tax rate: 34%; Free cash flow: $1B; Capex: $240M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188027\" data-linked=\"More on J.M. Smucker&#39;s FQ4\" data-tweet=\"$SJM - More on J.M. Smucker&#39;s FQ4 https://seekingalpha.com/news/3188027-on-j-m-smuckers-fq4?source=tweet\" data-url=\"https://seekingalpha.com/news/3188027-on-j-m-smuckers-fq4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3188012\" data-ts=\"1465468838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBK\" target=\"_blank\">CBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3188012-on-christopher-banks-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Christopher &amp; Banks&#39; Q1</a></h4><ul>     <li>Christopher &amp; Banks (NYSE:<a href=\"https://seekingalpha.com/symbol/CBK\" title=\"Christopher &amp; Banks Corporation\">CBK</a>) reports comparable sales rose 6% in Q1.</li>     <li>Gross margin rate improved 250 bps to 37.7%.</li>     <li>SG&amp;A expense rate grew 60 bps to 35.5%.</li>     <li>\n<b>Q2 Guidance</b>: Net sales: $92M to $96M; Gross margin rate: 33.9% to 35.1%; SG&amp;A expense: ~$32M to $33M; D&amp;A: ~$3.2M; Average square footage: flat Y/Y.</li>     <li>\n<b>FY2016 Guidance</b>: Capex: ~$12.5M to $13M; Average square footage: ~-1% Y/Y.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3188012\" data-linked=\"More on Christopher &amp; Banks&#39; Q1\" data-tweet=\"$CBK $CBKC - More on Christopher &amp; Banks&#39; Q1 https://seekingalpha.com/news/3188012-on-christopher-banks-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3188012-on-christopher-banks-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 AM </div></div></li>","count":49,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}